Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of WGS is 148 and suggests 11% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to decre
Buy
Sell